Jane Street’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Jane Street’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,191	Closed	-$40.1K	–	9579
2023 Q2	$40.1K	Buy	12,191 +11,469	+1,589%	+$34.7K	﹤0.01%	8256
2023 Q1	$6.56K	Sell	722 -8,210	-92%	-$116K	﹤0.01%	8787
2022 Q4	$105K	Buy	8,932 +5,912	+196%	+$104K	﹤0.01%	8060
2022 Q3	$64K	Sell	3,020 -228	-7%	-$6.15K	﹤0.01%	8836
2022 Q2	$79K	Buy	3,248 +2,128	+190%	+$72.4K	﹤0.01%	8764
2022 Q1	$56K	Sell	1,120 -297	-21%	-$14.7K	﹤0.01%	9655
2021 Q4	$100K	Sell	1,417 -4,976	-78%	-$419K	﹤0.01%	9256
2021 Q3	$597K	Sell	6,393 -309	-5%	-$29.4K	﹤0.01%	6947
2021 Q2	$674K	Buy	6,702 +1,264	+23%	+$123K	﹤0.01%	6667
2021 Q1	$508K	Buy	5,438 +1,894	+53%	+$192K	﹤0.01%	6779
2020 Q4	$292K	Sell	3,544 -1,937	-35%	-$165K	﹤0.01%	6462
2020 Q3	$470K	Buy	5,481 +2,740	+100%	+$319K	﹤0.01%	5241
2020 Q2	$255K	Buy	+2,741	New	+$151K	﹤0.01%	6074
2019 Q4	–	Sell	-1,066	Closed	-$15K	–	5922
2019 Q3	$15K	Sell	1,066 -3,868	-78%	-$81K	﹤0.01%	4963
2019 Q2	$173K	Buy	+4,934	New	+$268K	﹤0.01%	4732
2018 Q3	–	Sell	-4,010	Closed	-$331K	–	5844
2018 Q2	$331K	Buy	+4,010	New	+$387K	﹤0.01%	4023

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Jane Street's VBIV Position: Q3 2023 in Review

Jane Street sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2023, closing a stake of 12,191 shares — an estimated $40.1K sold.

Jane Street first reported a position in VBIV in Q2 2018 and held it in 16 quarters. The position peaked at $674K in Q2 2021. 37 funds tracked by Wall St. Rank hold VBIV as of Q3 2023.

Jane Street reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2023 after selling out during the quarter.
Jane Street sold 12,191 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2023, an estimated $40.1K.
Jane Street first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q2 2018 and held it in 16 quarters.
Jane Street's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $674K in Q2 2021.
37 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.